All of the sub-projects rely on the availability of high quality and high purity human cardiomyocytes that have been derived from patient-specific induced pluripotent stem cells (iPSCs).The overall objective of the Stem Cell Core is to provide the infrastructure, materials, and expertise to support the maintenance, derivation and differentiation of human pluripotent stem cells for PPG investigators. Although primary human cardiomyocytes could ostensibly be collected from patients, the logistics involved in harvesting cells from both control and type 2 diabetic populations make this approach infeasible. In addition, primary cardiac cells have a limited lifespan and cannot be expanded to provide the cell numbers necessary to meet the goals of the PPG. In contrast, human iPSCs can act as an indefatigable reservoir of human cardiomyocytes that can be cultured for over one year.
The specific aims of the Stem Cell Core are therefore to: (1) Reprogram new iPSC lines from non-diabetic and type 2 diabetic patients; (2) Generate reagents under strict quality control that are necessary for iPSC culture; (3) Provide training in the culture, handling, and differentiation of human iPSCs as required by PPG investigators; and (4) Supply purified iPSC-derived cardiomyocytes expressing enhanced green fluorescent protein to PPG investigators.
|Bosnjak, Zeljko J; Ge, Zhi-Dong (2017) The application of remote ischemic conditioning in cardiac surgery. F1000Res 6:928|
|Liu, Yanan; Baumgardt, Shelley L; Fang, Juan et al. (2017) Transgenic overexpression of GTP cyclohydrolase 1 in cardiomyocytes ameliorates post-infarction cardiac remodeling. Sci Rep 7:3093|
|Sedlic, Filip; Muravyeva, Maria Y; Sepac, Ana et al. (2017) Targeted Modification of Mitochondrial ROS Production Converts High Glucose-Induced Cytotoxicity to Cytoprotection: Effects on Anesthetic Preconditioning. J Cell Physiol 232:216-24|
|Mattson, David L; Liang, Mingyu (2017) Hypertension: From GWAS to functional genomics-based precision medicine. Nat Rev Nephrol 13:195-196|
|Stowe, David F; Yang, Meiying; Heisner, James S et al. (2017) Endogenous and Agonist-induced Opening of Mitochondrial Big Versus Small Ca2+-sensitive K+ Channels on Cardiac Cell and Mitochondrial Protection. J Cardiovasc Pharmacol 70:314-328|
|Chuppa, Sandra; Liang, Mingyu; Liu, Pengyuan et al. (2017) MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4. Kidney Int :|
|Camara, Amadou K S; Zhou, YiFan; Wen, Po-Chao et al. (2017) Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target. Front Physiol 8:460|
|Baker, Maria Angeles; Davis, Seth J; Liu, Pengyuan et al. (2017) Tissue-Specific MicroRNA Expression Patterns in Four Types of Kidney Disease. J Am Soc Nephrol 28:2985-2992|
|Liu, Yanan; Yan, Yasheng; Inagaki, Yasuyoshi et al. (2017) Insufficient Astrocyte-Derived Brain-Derived Neurotrophic Factor Contributes to Propofol-Induced Neuron Death Through Akt/Glycogen Synthase Kinase 3?/Mitochondrial Fission Pathway. Anesth Analg 125:241-254|
|Yang, MeiYing; Camara, Amadou K S; Aldakkak, Mohammed et al. (2017) Identity and function of a cardiac mitochondrial small conductance Ca2+-activated K+ channel splice variant. Biochim Biophys Acta 1858:442-458|
Showing the most recent 10 out of 124 publications